Ambrx, Merck collaborate to develop biologic drug conjugates
10:40 EDT 18 Jun 2012 | Pharmaceutical Business Review
Ambrx has signed a collaboration agreement with Merck to design and develop rationally optimized biologic drug conjugates based on Ambrx's site-specific protein medicinal chemistry technology.
Original Article: Ambrx, Merck collaborate to develop biologic drug conjugates
More From BioPortfolio on "Ambrx, Merck collaborate to develop biologic drug conjugates"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
